Here is a summary of everything you need to know about our summit
Over 1 million adverse drug reactions are reported each year in Europe alone, highlighting the urgent need for vigilant pharmacovigilance practices. In today’s complex landscape, pharmacovigilance has become more essential than ever, with challenges like adverse reactions, unpredictable drug interactions, and gaps in cross-border regulations creating significant risks for patient safety. Join us at Pronovea’s 4th edition of Drug Safety and Risk Management Summit as we explore transformative trends, embrace real-world evidence, navigate the latest updates in pharmacovigilance and expanding its scope to address the emerging issues in pharmacovigilance today, offering new perspectives and actionable strategies that reflect the latest industry trends and challenges.